• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ChemoMetec

377.80 DKK

+0.85 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+0.85 %
+20.55 %
-5.46 %
-45.05 %
-46.11 %
-28.85 %
-26.64 %
-52.09 %
+1,617.27 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
6.57B DKK
Turnover
19.9M DKK
Revenue
495.57M
EBIT %
47.73 %
P/E
35.28
Dividend yield-%
1.85 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
10/9
2026

Annual report '26

8/10
2026

General meeting '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/15/2026, 9:43 AM

Initiation of buy-back programme

ChemoMetec
Regulatory press release5/6/2026, 4:52 PM

Growth in revenue and operating profit

ChemoMetec
Regulatory press release5/4/2026, 1:17 PM

Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/27/2026, 9:06 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/27/2026, 8:53 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/26/2026, 10:40 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/24/2026, 3:08 PM

Adjustment of guidance for 2025/26

ChemoMetec
Regulatory press release3/2/2026, 9:50 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release2/9/2026, 9:28 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release2/4/2026, 5:16 PM

ChemoMetec enters Letter of Intent with Roche Diagnostics

ChemoMetec
Regulatory press release2/4/2026, 5:09 PM

Interim report 2025/26 - Organic growth despite challenges in the North American market

ChemoMetec
Regulatory press release11/7/2025, 12:27 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/7/2025, 12:18 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/6/2025, 4:11 PM

Growth in revenue and operating profit

ChemoMetec
Regulatory press release10/28/2025, 10:06 AM

Upgrade of guidance

ChemoMetec
Regulatory press release10/9/2025, 8:01 PM

Procedure of the Annual General Meeting

ChemoMetec
Regulatory press release9/17/2025, 1:43 PM

Notice of Annual General Meeting 2025

ChemoMetec
Regulatory press release9/11/2025, 5:16 PM

Annual Report 2024/25 - Growing revenue and EBITDA

ChemoMetec
Regulatory press release9/11/2025, 5:12 PM

Guidance for the 2025/26 financial year

ChemoMetec
Regulatory press release7/1/2025, 10:45 AM

Preliminary revenue figures for the 2024/25 financial year

ChemoMetec